Latest News and Press Releases

Washington, DC, May 08, 2019 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. hereby provides the following corporate update to the Company’s shareholders. A copy of the update can also be found on the...

Washington, DC, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. ("Avant" or the “Company”) (OTC Pink: AVDX), announced today that trading in its common stock has been temporarily...

SCOTTSDALE, Ariz. and GAITHERSBERG, Md., June 14, 2016 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. (“Avant”) (OTCQB:AVDX), an innovative molecular diagnostics company, today announced that Dr. Vince...

SCOTTSDALE, Ariz. and GAITHERSBERG, Md., May 31, 2016 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. (“Avant”) (OTCQB:AVDX), an innovative molecular diagnostics company, today announced that Company...

SCOTTSDALE, Ariz. and GAITHERSBERG, Md., May 19, 2016 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. (“Avant”) (OTCQB:AVDX), an innovative molecular diagnostics company, today announced the acceptance...

Operations of Amarantus Diagnostics and Theranostics Health have consolidated into Avant Diagnostics (OTCQB:AVDX)Diagnostics pipeline in Alzheimer’s disease (LymPro Test™), Ovarian cancer (OvaDx™) and...

SAN FRANCISCO and SCOTTSDALE, Ariz., Jan. 19, 2016 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQX:AMBS), a biotechnology company developing products in Regenerative Medicine,...

SCOTTSDALE, Ariz., Jan. 15, 2016 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. (OTCQB:AVDX), "Avant", announces that CEO Gregg Linn will be presenting at the NobleCon12 - Noble Financial Capital...

SCOTTSDALE, Ariz., Oct. 07, 2015 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. (OTCQB:AVDX) (“Avant”), an innovative in vitro diagnostics company, was notified by DOCRO, its independent clinical...

SCOTTSDALE, Ariz., Sept. 24, 2015 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. (OTCQB:AVDX) ("Avant"), an innovative molecular diagnostics company, began calibration testing in preparation for the...